← Ishga qaytish
Ushbu ishga iqtibos qilgan ishlar
2 ta ish
Ish: Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)